Australian Capital Markets Stock News

As the Australian market navigates Week 5 with a renewed focus on precious metals and an equity upswing, investors are eyeing opportunities amidst a "risk-on" sentiment that echoes early 2022. In this dynamic environment, dividend stocks like Cash Converters International offer potential appeal for those seeking steady income streams in a fluctuating market.

As the Australian market kicks off Week 5 with a surge in precious metals and a notable equity hike, investors are closely watching how these movements align with global trends where major indices like the S&P 500 and FTSE are showing positive momentum. In this context, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment of interests, making them potential candidates for those looking to navigate the...

As the Australian stock market navigates a "risk-on" environment, fueled by an uptick in precious metals and a positive shift in share futures, investors are keenly observing opportunities that may present undervalued prospects. In this context, identifying stocks trading below their intrinsic value becomes crucial for those looking to capitalize on potential market inefficiencies.

As the Australian market enters Week 5 with a notable rise in precious metals and equities, small-cap stocks are drawing attention amid a "risk-on" sentiment that echoes early 2022. In this dynamic environment, identifying promising small caps requires an eye for companies poised to benefit from current economic trends and sector-specific developments.

American Rare Earths (ASX:ARR) drew fresh investor attention after securing a National Science Foundation research award with the University of Wyoming to study commercial uses for mining byproducts at its Halleck Creek rare earths project. See our latest analysis for American Rare Earths. Those research headlines arrive after a strong run in the share price, with a 30 day share price return of 20.55% and a year to date gain of 22.22%. The 1 year total shareholder return of 60% and 5 year...

Citi recently highlighted improved drilling momentum at Perenti, pointing to operational progress in the company’s core drilling services segment. This renewed focus on drilling activity underscores how operational trends within Perenti’s core business can meaningfully influence investor perceptions of the group. We’ll now examine how Citi’s emphasis on stronger drilling momentum could shape Perenti’s broader investment narrative for investors. Explore 23 top quantum computing companies...

Woolworths Group (ASX:WOW) has refined core processes across its supermarket network to support better product availability and shelf management. The changes are being rolled out across stores, targeting more consistent on shelf stock and cleaner, easier to shop layouts for customers. For you as an investor, this sits right at the heart of Woolworths Group's supermarket business, which remains a key part of the ASX:WOW story. The company operates one of Australia's largest grocery chains,...

In recent trading, Westpac Banking came under pressure as investors reacted cautiously to upcoming Australian December‑quarter inflation data and the Reserve Bank of Australia’s pending policy decision. This macro focus matters for Westpac because inflation and rate outcomes directly influence its net interest margins, funding costs and credit growth outlook. We’ll now examine how this inflation‑driven focus on future RBA decisions could shape Westpac’s investment narrative for...

Dateline Resources (ASX:DTR) has drawn fresh attention after completing an A$35 million institutional placement to accelerate work at its Colosseum gold project in the US, including equipment orders and early construction preparation. See our latest analysis for Dateline Resources. The placement and Colosseum updates have come alongside sharp share price momentum, with a 30 day share price return of 97.83% and a year to date share price return of 106.82%. The 1 year total shareholder return...

Why Worley’s H2East pipeline win matters for investors Worley (ASX:WOR) has secured the Front End Engineering Design and Development Consent Order work for Cadent’s H2East hydrogen pipeline in the UK, putting its low carbon project capabilities in sharper focus for investors. See our latest analysis for Worley. Worley’s latest hydrogen contract lands at a time when momentum in the shares has recently picked up, with a 1-month share price return of 5.07% and a year to date share price return...

Mirvac Group (ASX:MGR) has had a rough three months with its share price down 16%. To decide if this trend could...

Key Insights Significant control over Infragreen Group by retail investors implies that the general public has more...

Peak Processing Limited's ( ASX:PKP ) price-to-sales (or "P/S") ratio of 1.2x might make it look like a strong buy...

Key Insights The projected fair value for Temple & Webster Group is AU$13.87 based on 2 Stage Free Cash Flow to Equity...

Key Insights Given the large stake in the stock by institutions, Aspen Group's stock price might be vulnerable to their...

As the Australian market embraces a "risk-on" sentiment, with precious metals and equity indices experiencing notable hikes, investors are keenly observing opportunities that align with current economic trends. Penny stocks, while often considered niche investments, present intriguing prospects for those looking to capitalize on smaller or newer companies with potential growth. These stocks can offer a blend of affordability and opportunity when supported by strong financials; let's examine a...

REA Group Limited ( ASX:REA ) shareholders might be concerned after seeing the share price drop 15% in the last...

Why the Uber Eats deal matters for Guzman y Gomez shares Guzman y Gomez (ASX:GYG) has signed an exclusive multi year partnership that makes Uber Eats its only third party delivery platform in Australia, a shift that directly affects a key sales channel. See our latest analysis for Guzman y Gomez. The Uber Eats partnership comes after a mixed period for the stock, with a 1 day share price return of 3.83% and a 7 day share price return of 6.10%, but a 1 year total shareholder return decline of...

Why Boab Metals’ latest shareholder vote matters for investors Boab Metals (ASX:BML) has confirmed that all resolutions at its 23 January 2026 General Meeting passed, including approvals for prior and future share issues linked to its current capital management plans. This outcome gives the company room to proceed with its planned equity funding under ASX Listing Rules 7.1 and 7.1A. This keeps placement capacity in line with listing requirements and supports financial flexibility. See our...

DroneShield Limited ( ASX:DRO ) shareholders are no doubt pleased to see that the share price has bounced 36% in the...

Follow on equity offer puts 4DMedical in focus 4DMedical (ASX:4DX) has drawn fresh investor attention after completing a follow on equity offering, raising A$79.06 million through the issue of more than 20,806,000 new ordinary shares at A$3.80 each. See our latest analysis for 4DMedical. Despite the capital raise pricing the new shares at A$3.80, 4DMedical’s latest share price of A$4.05 sits above that level. The 90 day share price return is above 100% and the 1 year total shareholder return...

Supply Network Limited has declared a fully franked interim dividend of A$0.36 per share for the six months ended 31 December 2025, with a record date of 19 March 2026, an ex-dividend date of 18 March 2026, and payment due on 2 April 2026. This dividend decision, alongside the company’s indication of approximately A$22.9 million in half-year profit after tax, highlights management’s confidence in current cash generation and business resilience in the commercial vehicle aftermarket parts...

Telix Pharmaceuticals (ASX:TLX) is back in focus after Chinese regulators accepted a New Drug Application for its Illuccix prostate cancer imaging agent, and the company reported first patient dosing in a US Phase 3 diagnostic trial. See our latest analysis for Telix Pharmaceuticals. Despite the regulatory momentum in China and the US, Telix’s share price return over the past 90 days shows a 34.31% decline, contributing to a 60.23% drop in 1-year total shareholder return. However, the 5-year...

In January 2026, IperionX announced a US$300,000 prototype purchase order from American Rheinmetall to supply 700 U.S.-made, lightweight titanium components for U.S. Army heavy ground combat systems using 100% recycled titanium via its HAMR and HSPT processes. This order highlights IperionX’s role as the only commercial-scale U.S. primary titanium producer, directly supporting efforts to reshore critical defense metal supply chains while testing its lower-cost, recycled titanium technologies...